Genetische Befunde bei Angsterkrankungen

Zusammenfassung

An der Entstehung von Angsterkrankungen sind neben psychosozialen auch genetische Faktoren beteiligt. Klinische Studien haben insbesondere Hinweise auf einen Beitrag genetischer Faktoren zur Entstehung der Panikstörung von ungefähr 48 % erbracht. Für Panikstörung, aber auch für andere Angsterkrankungen gibt es erste molekulargenetische Befunde. Diese Befunde könnten die Grundlage für neue Therapieansätze liefern.

Summary

Psychosocial as well as genetic factors contribute to the pathogenesis of anxiety disorders. Clinical studies have in particular provided evidence for a genetic liability to panic disorder of about 48 %. Evidence for the association of genes with panic disorder, but also with other anxiety disorders has been reported. These findings may provide the basis for the development of innovative therapies.

Key Words

anxiety disorders - panic disorder - heritability - association studies - monoamine oxidase A - intermediate phenotypes

Literatur

• 1 Bandelow B. Panik und Agoraphobie. Diagnose, Ursachen und Behandlung.  Wien, Springer Verlag. 2001; 
• 2 Bandelow B, Spath C. et al. . Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder.  Compr Psychiatry. 2002;  43 269-278
• 3 Deckert J, Catalano M. et al. . Excess of high activity monoamine oxidase A gene promotor alleles in female patients with panic disorder.  Hum Mol Genet. 1999;  8 621-624
• 4 Deckert J, Kuhlenbäumer G. et al. . Chromosome 22q11.2 as a candidate gene locus: Association of the more active COMT-allele with panic disorder.  Am J Med Genet. 2001;  105
• 5 Domschke K, Kuhlenbäumer G. et al. . Human nuclear transcription factor gene CREM: Genomic organization, mutation screening and association analysis in panic disorder.  Am J Med Genet (Neuropsychiatric Genetics). 2003;  117B 70-78
• 6 Fava M, Rosenbaum JF. et al. . Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.  J Clin Psychopharmacol. 1999;  19 329-335
• 7 Hamilton SP, Slager SL. et al. . Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22.  Biol Psychiatry. 2002;  15 129-140
• 8 Hettema JM, Neale MC. et al. . A review and meta-analysis of the genetic epidemiology of anxiety disorders.  Am J Psychiatry. 2001;  158 1568-1578
• 9 Hösing V, Kuhlenbäumer G. et al. . CCK Neurotransmitter system gene polymorphisms - Association analysis in two independent German panic disorder samples.  Am J Med Gen (Neuropsychiatric Genetics). 2002;  115 837
• 10 Kendler KS, Karkowski LM. et al. . Fears and phobias: reliability and heritability.  Psychol Med. 1999;  29 539-553
• 11 Kennedy JL, Bradwejn J. et al. . Investigation of cholecystokinin system genes in panic disorder.  Mol Psychiatry. 1999;  4 284-285
• 12 Maier W, Lichtermann D. et al. . A controlled family study in panic disorder.  J Psychiatr Res. 1993;  27 79-87
• 13 Smoller JW, Tsuang MT.. Panic and phobic anxiety: Defining phenotypes for genetic studies.  Am J Psychiatry. 1998;  155 1152-1162
• 14 Thorgeirsson TE, Skarsson H. et al. . Genome-wide significant linkage to chromosome 9 for panic disorder and anxiety in Iceland.  Am J Med Gen (Neuropsychiatric Genetics). 2002;  114 738
• 15 True WR, Rice J. et al. . A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms.  Arch Gen Psychiatry. 1993;  50 257-264
• 16 Tyrer P, Shawcross C.. Monoamine oxidase inhibitors in anxiety disorders.  J Psychiatry Res. 1988;  22 87-98
• 17 Weissman MM, Bland RC. et al. . The cross-national epidemiology of panic disorder.  Arch Gen Psychiatry. 1997;  54 305-309
• 18 Woo JM, Yoon KS. et al. . Catechol-O-methyltransferase genetic polymorphism in panic disorder.  Am J Psychiatry. 2002;  159 1785-1787

Korrespondenzadresse: